DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ rallied 2.31% to $179.10 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.79% to 5,405.97 and the Dow Jones Industrial Average rising 0.78% to 40,524.79.
This was the stock's second consecutive day of gains.
AbbVie Inc. closed 18.09% below its 52-week high of $218.66, which the company reached on March 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.73% to $154.36, Pfizer Inc. $(PFE)$ rose 0.96% to $22.12, and Amgen Inc. $(AMGN)$ rose 2.78% to $293.92.
Trading volume (7.1 M) remained 429,269 below its 50-day average volume of 7.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 14, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 14, 2025 16:31 ET (20:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。